Trade Agilon health, inc. - AGL CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
| Long position overnight fee | -0.0225% |
| Short position overnight fee | -0.0219% |
| Overnight fee time | 21:00 (UTC) |
| Min traded quantity | 1 |
| Currency | USD |
| Margin | 20% |
| Stock exchange | United States of America |
| Commission on trade | 0% |
*Information provided by Capital.com
| Prev. Close* | 20.98 |
| Open* | 20.51 |
| Day's Range* | 20.4 - 20.4 |
| 1-Year Change* | -40.55% |
| Volume | N/A |
| Average Vol. (3m) | 48.9291 |
| 52 wk Range | N/A |
| Market Cap | 8670.76 |
| P/E Ratio | N/A |
| Shares Outstanding | 410936000 |
| Revenue | 2245.08 |
| EPS | -0.28855 |
| Dividend (Yield %) | N/A |
| Beta | N/A |
| Next Earnings Date | Oct 26, 2022 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Aug 18, 2022 | 20.61 | -0.25 | -1.20% | 20.86 | 21.02 | 20.01 |
| Aug 17, 2022 | 20.98 | -0.86 | -3.94% | 21.84 | 22.10 | 20.72 |
| Aug 16, 2022 | 22.29 | -0.33 | -1.46% | 22.62 | 23.28 | 21.97 |
| Aug 15, 2022 | 23.19 | 0.37 | 1.62% | 22.82 | 23.41 | 22.17 |
| Aug 12, 2022 | 23.35 | 0.32 | 1.39% | 23.03 | 23.56 | 22.10 |
| Aug 11, 2022 | 25.64 | -1.83 | -6.66% | 27.47 | 28.21 | 25.16 |
| Aug 10, 2022 | 26.95 | 0.58 | 2.20% | 26.37 | 27.02 | 26.14 |
| Aug 9, 2022 | 26.22 | -0.14 | -0.53% | 26.36 | 26.98 | 25.61 |
| Aug 8, 2022 | 26.95 | 1.09 | 4.22% | 25.86 | 27.51 | 25.44 |
| Aug 5, 2022 | 25.56 | 1.00 | 4.07% | 24.56 | 25.56 | 23.07 |
| Aug 4, 2022 | 25.36 | -0.57 | -2.20% | 25.93 | 26.26 | 25.19 |
| Aug 3, 2022 | 26.31 | 0.70 | 2.73% | 25.61 | 26.55 | 25.23 |
| Aug 2, 2022 | 25.68 | 1.02 | 4.14% | 24.66 | 25.98 | 24.13 |
| Aug 1, 2022 | 24.94 | 0.36 | 1.46% | 24.58 | 25.25 | 24.06 |
| Jul 29, 2022 | 24.93 | 0.35 | 1.42% | 24.58 | 25.41 | 24.35 |
| Jul 28, 2022 | 25.03 | 0.30 | 1.21% | 24.73 | 25.33 | 24.32 |
| Jul 27, 2022 | 24.99 | -0.76 | -2.95% | 25.75 | 26.16 | 23.30 |
| Jul 26, 2022 | 25.84 | 0.97 | 3.90% | 24.87 | 26.44 | 24.64 |
| Jul 25, 2022 | 25.02 | 0.31 | 1.25% | 24.71 | 25.39 | 23.77 |
| Jul 22, 2022 | 25.11 | -2.25 | -8.22% | 27.36 | 27.43 | 24.24 |
Agilon health, inc. Events
| Time (UTC) | Country | Event |
|---|---|---|
| Wednesday, October 26, 2022 | ||
| 20:00 | | Q3 2022 agilon health inc Earnings Release |
- Annual
- Quarterly
| 2019 | 2020 | 2021 | |
|---|---|---|---|
| Total revenue | 794.411 | 1218.33 | 1833.56 |
| Revenue | 794.411 | 1218.33 | 1833.56 |
| Cost of Revenue, Total | 725.374 | 1021.88 | 1647.66 |
| Gross Profit | 69.037 | 196.456 | 185.9 |
| Total Operating Expense | 900.985 | 1275.01 | 2227.51 |
| Selling/General/Admin. Expenses, Total | 163.358 | 239.598 | 565.308 |
| Depreciation / Amortization | 12.253 | 13.531 | 14.544 |
| Operating Income | -106.574 | -56.673 | -393.952 |
| Interest Income (Expense), Net Non-Operating | -9.068 | -8.135 | -6.146 |
| Other, Net | 0.955 | 2.465 | -4.5 |
| Net Income Before Taxes | -114.687 | -62.343 | -404.598 |
| Net Income After Taxes | -114.455 | -63.208 | -405.484 |
| Net Income Before Extra. Items | -114.455 | -63.208 | -405.184 |
| Total Extraordinary Items | -168.133 | 3.156 | -1.303 |
| Net Income | -282.588 | -60.052 | -406.487 |
| Income Available to Common Excl. Extra. Items | -114.455 | -63.208 | -405.184 |
| Income Available to Common Incl. Extra. Items | -282.588 | -60.052 | -406.487 |
| Diluted Net Income | -282.588 | -60.052 | -406.487 |
| Diluted Weighted Average Shares | 384.022 | 384.022 | 372.931 |
| Diluted EPS Excluding Extraordinary Items | -0.29804 | -0.16459 | -1.08649 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | |
| Diluted Normalized EPS | -0.29804 | -0.16459 | -1.06331 |
| Minority Interest | 0.3 |
| Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Total revenue | 413.104 | 498.956 | 458.613 | 462.886 | 653.445 |
| Revenue | 413.104 | 498.956 | 458.613 | 462.886 | 653.445 |
| Cost of Revenue, Total | 360.354 | 442.483 | 414.202 | 430.62 | 566.208 |
| Gross Profit | 52.75 | 56.473 | 44.411 | 32.266 | 87.237 |
| Total Operating Expense | 425.219 | 797.319 | 494.214 | 510.759 | 654.188 |
| Selling/General/Admin. Expenses, Total | 61.438 | 351.255 | 76.097 | 76.518 | 84.607 |
| Depreciation / Amortization | 3.427 | 3.581 | 3.915 | 3.621 | 3.373 |
| Operating Income | -12.115 | -298.363 | -35.601 | -47.873 | -0.743 |
| Interest Income (Expense), Net Non-Operating | -2.941 | -1.498 | -0.867 | -0.84 | -0.871 |
| Other, Net | 1.336 | 2.967 | -0.269 | -8.534 | 2.269 |
| Net Income Before Taxes | -13.72 | -296.894 | -36.737 | -57.247 | 0.655 |
| Net Income After Taxes | -13.736 | -297.329 | -36.993 | -57.426 | 0.726 |
| Minority Interest | 0.073 | 0.096 | 0.115 | 0.016 | 0.075 |
| Net Income Before Extra. Items | -13.663 | -297.233 | -36.878 | -57.41 | 0.801 |
| Total Extraordinary Items | -1.415 | -1.612 | 1.035 | 0.689 | 0.429 |
| Net Income | -15.078 | -298.845 | -35.843 | -56.721 | 1.23 |
| Income Available to Common Excl. Extra. Items | -13.663 | -297.233 | -36.878 | -57.41 | 0.801 |
| Income Available to Common Incl. Extra. Items | -15.078 | -298.845 | -35.843 | -56.721 | 1.23 |
| Diluted Net Income | -15.078 | -298.845 | -35.843 | -56.721 | 1.23 |
| Diluted Weighted Average Shares | 384.022 | 377.445 | 391.229 | 396.67 | 424.065 |
| Diluted EPS Excluding Extraordinary Items | -0.03558 | -0.78749 | -0.09426 | -0.14473 | 0.00189 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| Diluted Normalized EPS | -0.03418 | -0.78086 | -0.09284 | -0.13201 | 0.0045 |
- Annual
- Quarterly
| 2019 | 2020 | 2021 | |
|---|---|---|---|
| Total Current Assets | 245.528 | 294.197 | 1367.19 |
| Cash and Short Term Investments | 123.633 | 106.795 | 1040.04 |
| Cash & Equivalents | 123.633 | 106.795 | 1040.04 |
| Total Receivables, Net | 93.254 | 144.555 | 293.407 |
| Accounts Receivable - Trade, Net | 93.254 | 144.555 | 293.407 |
| Prepaid Expenses | 4.312 | 9.639 | 18.968 |
| Other Current Assets, Total | 24.329 | 33.208 | 14.781 |
| Total Assets | 402.794 | 446.361 | 1586.25 |
| Property/Plant/Equipment, Total - Net | 18.836 | 16.041 | 20.9 |
| Property/Plant/Equipment, Total - Gross | 23.686 | 23.316 | 29.105 |
| Accumulated Depreciation, Total | -4.85 | -7.275 | -8.205 |
| Goodwill, Net | 41.54 | 41.54 | 41.54 |
| Intangibles, Net | 71.146 | 60.468 | 55.398 |
| Other Long Term Assets, Total | 25.744 | 34.115 | 94.529 |
| Total Current Liabilities | 199.61 | 266.835 | 356.96 |
| Payable/Accrued | 67.555 | 97.244 | 112.946 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 3.041 | 3.041 | 5 |
| Other Current Liabilities, Total | 129.014 | 166.55 | 239.014 |
| Total Liabilities | 353.822 | 421.591 | 494.356 |
| Total Long Term Debt | 67.143 | 64.665 | 43.401 |
| Long Term Debt | 67.143 | 64.665 | 43.401 |
| Other Liabilities, Total | 87.069 | 90.091 | 94.295 |
| Total Equity | 48.972 | 24.77 | 1091.9 |
| Common Stock | 283.467 | 311.994 | 4.001 |
| Additional Paid-In Capital | 256.643 | 263.966 | 2045.57 |
| Retained Earnings (Accumulated Deficit) | -491.138 | -551.19 | -957.677 |
| Total Liabilities & Shareholders’ Equity | 402.794 | 446.361 | 1586.25 |
| Total Common Shares Outstanding | 384.022 | 384.022 | 400.095 |
| Long Term Investments | 6.69 | ||
| Minority Interest | -0.3 |
| Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Total Current Assets | 417.632 | 1479.81 | 1452.87 | 1367.19 | 1627.94 |
| Cash and Short Term Investments | 105.289 | 1109.37 | 1081.6 | 1040.04 | 1021.75 |
| Cash & Equivalents | 105.289 | 1109.37 | 1081.6 | 1040.04 | 1021.75 |
| Total Receivables, Net | 288.827 | 338.359 | 342.5 | 293.407 | 571.869 |
| Accounts Receivable - Trade, Net | 288.827 | 338.359 | 342.5 | 293.407 | 571.869 |
| Prepaid Expenses | 9.314 | 15.74 | 14.463 | 18.968 | 19.847 |
| Other Current Assets, Total | 14.202 | 16.343 | 14.302 | 14.781 | 14.47 |
| Total Assets | 574.038 | 1701.73 | 1685.12 | 1586.25 | 1855.21 |
| Property/Plant/Equipment, Total - Net | 14.399 | 13.797 | 10.266 | 20.9 | 24.568 |
| Goodwill, Net | 41.54 | 41.54 | 41.54 | 41.54 | 41.54 |
| Intangibles, Net | 61.609 | 58.663 | 58.147 | 55.398 | 53.709 |
| Other Long Term Assets, Total | 38.858 | 107.92 | 122.301 | 101.219 | 96.218 |
| Total Current Liabilities | 372.106 | 412.33 | 422.781 | 356.96 | 610.461 |
| Payable/Accrued | 95.122 | 107.599 | 129.66 | 112.946 | 133.138 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 0 | 3.75 | 5 | 5 | 5 |
| Other Current Liabilities, Total | 276.984 | 300.981 | 288.121 | 239.014 | 472.323 |
| Total Liabilities | 562.709 | 551.287 | 557.397 | 494.356 | 743.359 |
| Total Long Term Debt | 99.412 | 45.862 | 44.628 | 43.401 | 42.172 |
| Long Term Debt | 99.412 | 45.862 | 44.628 | 43.401 | 42.172 |
| Minority Interest | -0.073 | -0.169 | -0.284 | -0.3 | -0.375 |
| Other Liabilities, Total | 91.264 | 93.264 | 90.272 | 94.295 | 91.101 |
| Total Equity | 11.329 | 1150.45 | 1127.72 | 1091.9 | 1111.85 |
| Common Stock | 311.994 | 3.909 | 3.915 | 4.001 | 4.057 |
| Additional Paid-In Capital | 265.603 | 2011.65 | 2024.76 | 2045.57 | 2064.24 |
| Retained Earnings (Accumulated Deficit) | -566.268 | -865.113 | -900.956 | -957.677 | -956.447 |
| Total Liabilities & Shareholders’ Equity | 574.038 | 1701.73 | 1685.12 | 1586.25 | 1855.21 |
| Total Common Shares Outstanding | 384.022 | 390.883 | 393.655 | 400.095 | 405.727 |
| Long Term Investments | 11.236 |
- Annual
- Quarterly
| 2019 | 2020 | 2021 | |
|---|---|---|---|
| Net income/Starting Line | -282.74 | -60.052 | -406.787 |
| Cash From Operating Activities | -103.861 | -53.204 | -148.159 |
| Cash From Operating Activities | 41.413 | 14.099 | 14.67 |
| Deferred Taxes | -16.177 | -2.809 | -3.231 |
| Non-Cash Items | 120.466 | -10.914 | 302.214 |
| Cash Taxes Paid | 0.026 | 0.002 | 1.819 |
| Cash Interest Paid | 8.038 | 7.086 | 4.824 |
| Changes in Working Capital | 33.177 | 6.472 | -55.025 |
| Cash From Investing Activities | -5.06 | 22.066 | -90.506 |
| Capital Expenditures | -3.906 | -2.35 | -13.426 |
| Other Investing Cash Flow Items, Total | -1.154 | 24.416 | -77.08 |
| Cash From Financing Activities | 176.298 | 24.621 | 1154.39 |
| Financing Cash Flow Items | -0.303 | 0 | -14.739 |
| Issuance (Retirement) of Stock, Net | 180.193 | 27.662 | 1189.03 |
| Issuance (Retirement) of Debt, Net | -3.592 | -3.041 | -19.899 |
| Net Change in Cash | 67.377 | -6.517 | 915.725 |
| Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -15.151 | -314.092 | -350.05 | -406.787 | 1.155 |
| Cash From Operating Activities | -40.828 | -80.119 | -99.262 | -148.159 | -23.233 |
| Cash From Operating Activities | 3.481 | 7.095 | 11.032 | 14.67 | 3.373 |
| Non-Cash Items | 4.424 | 277.089 | 287.379 | 302.214 | 2.493 |
| Cash Taxes Paid | 0.016 | 1.635 | 1.738 | 1.819 | 3.098 |
| Cash Interest Paid | 1.921 | 2.907 | 3.853 | 4.824 | 0.959 |
| Changes in Working Capital | -33.582 | -50.211 | -47.623 | -55.025 | -30.254 |
| Cash From Investing Activities | -9.074 | -76.338 | -87.903 | -90.506 | -8.869 |
| Capital Expenditures | -4.164 | -4.664 | -9.958 | -13.426 | -5.049 |
| Other Investing Cash Flow Items, Total | -4.91 | -71.674 | -77.945 | -77.08 | -3.82 |
| Cash From Financing Activities | 30.298 | 1143.08 | 1143.97 | 1154.39 | 13.506 |
| Financing Cash Flow Items | -1.218 | -9.768 | -9.928 | -14.739 | 0 |
| Issuance (Retirement) of Stock, Net | 0.165 | 1171.49 | 1172.55 | 1189.03 | 14.756 |
| Issuance (Retirement) of Debt, Net | 31.351 | -18.648 | -18.647 | -19.899 | -1.25 |
| Net Change in Cash | -19.604 | 986.62 | 956.808 | 915.725 | -18.596 |
| Deferred Taxes | -3.231 |
Why choose Capital.com? Our numbers speak for themselves.
Capital.com GroupTraders
Active clients monthly
Monthly investing volume
Withdrawn each month
Agilon Health Company profile
Track the Agilon share price today and spot the best levels for profitable CFD trades.
Agilon Health, inc (AGL) is a US-based healthcare company, providing a transformative healthcare platform for seniors. It empowers primary-care physicians (PCP) to focus on the entire health of their patients.
Agilon platform builds long-term partnership models with physician groups across the United States. It aims to create a Medicare-centric business which is capable of driving significant change in quality, patient experience and cost of healthcare services for seniors.
The company was founded in 2016 and established its first partnership with a physician group in 2017. In less than five years Agilon expanded its network up to 16 physician groups and 17 geographies.
Agilon platform increased its revenue by 53 per cent and total membership by 45 per cent from December 31, 2019 to December 31, 2020. Today primary-care physicians serve around 210,000 patients enrolled in Medicare Advantage healthcare plans.
Medicare Advantage is the term used by the US Centres for Medicare and Medical Services to define all-inclusive Medicare coverage for seniors.
The company refers to its platform as a first-of-its-kind Total Care Model for community-based physicians, which aims to bring capitated costs to physician groups that treat many Medicare Advantage patients.
Agilon stock price floated on the New York Stock Exchange (NYSE) under the ticker symbol AGL. The California-based provider of support services for primary-care physicians went public on April 15, 2021 at $23 per share, at the top of the estimated price range between $20 and $23, which gave it a $8.85bn valuation.
Agilon Health offered 46.6 million shares in the IPO, which raised $1.07bn. The company’s lead underwriters were Goldman Sachs, JPMorgan and BofA Securities. The AGL share price chart saw the price of Agilon soar 38 per cent to close at $31 on its first day of trading as a public company.
According to the company’s IPO prospectus, Agilon revealed a net loss of $60.1m on revenue of $1.22bn in 2020, compared to the loss of $282.6m on revenue of $794.4m in 2019.
Today you can trade AGL shares with CFDs directly from the interactive AGL share price chart at Capital.com. Follow AGL share price and decide whether to open a long or a short trade, depending on the stock’s performance. Track the AGL stock price today and include this popular healthcare company into your investment portfolio.
| Industry: | Doctor's Office |
6210 E Hwy 290
Suite 450
AUSTIN
TEXAS 78723
US
Income statement
News
Is the copper bear market rally already over?
Copper has only managed to recover about 16% from its mid-July lows, facing resistance caused by the 50-dma
06:00, 19 August 2022
Stata Bank of India subsidiary: Stock upside left in the short term
SBI share price could pick up from hereon after it took support at 50 DEMA
05:45, 19 August 2022
Nifty 50 today: range bound trend emerging over global cues, say analysts
India 50 could be looking for directions on Friday over global cues and upbeat domestic conditions
02:26, 19 August 2022
Telling the story of three key Chapter 11 crypto cases
Several firms are going through ‘reorganization’ bankruptcy in the cryptosphere
01:35, 19 August 2022
Structure uses cryptocurrencies to serve as a wider market
Firm offers digital asset investments, not payment services
00:18, 19 August 2022People Also Watch
Ripple to US Dollar
| Long position overnight fee | -0.0500% |
| Short position overnight fee | 0.0140% |
| Overnight fee time | 21:00 (UTC) |
| Spread | 0.00600 |
Still looking for a broker you can trust?
Join the 427.000+ traders worldwide that chose to trade with Capital.com
